Trials / Completed
CompletedNCT05585021
Clinical Study on the Effect of Probiotic Compound Powder on the Immunity Improvement of Preschool Children
A Clinical Study on The Effect of Probiotic Compound Powder (WONDERLAB) on The Immunity Improvement of Preschool Children (RCT)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Shenzhen Precision Health Food Technology Co. Ltd., · Other Government
- Sex
- All
- Age
- 5 Years – 6 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized controlled trial, to evaluate the effect of WONDERLAB Probiotic Compound Powder on improving immunity of preschool children
Detailed description
The community hospital will recruit 140 preschool children, aged 5 to 6 years old, according to the inclusion and exclusion criteria, and randomly assigned them to 2 groups. 70 subjects in the placebo group and 70 in the experimental product group. First entered a one-week washout period, and then entered a 25-week clinical intervention, and finally ensured that 100 volunteers completed the whole study, and the withdrawal rate was about 28%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Wonderlab Kids instant probiotics | During study intervention, subjects are required to take the randomly assigned product based on the randomization list. Taking assigned product directly or mix it with milk/water/other liquids below 37 ℃, take it half an hour after meal.1 bottle a day. Lasting for 24 weeks intervention period. |
| DIETARY_SUPPLEMENT | Instant probiotic placebo | Subjects are required to take the randomly assigned Instant probiotic placebo based on the randomization list. Taking assigned product directly or mix it with milk/water/other liquids below 37 ℃, half an hour after meal. 1 bottle a day. Lasting for 24 weeks intervention period. |
Timeline
- Start date
- 2022-10-19
- Primary completion
- 2023-04-30
- Completion
- 2023-04-30
- First posted
- 2022-10-18
- Last updated
- 2023-11-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05585021. Inclusion in this directory is not an endorsement.